Literature DB >> 15582469

Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases.

Vannakambadi K Ganesh1, Nik Muller, Ken Judge, Chi-Hao Luan, Radhakrishnan Padmanabhan, Krishna H M Murthy.   

Abstract

The 72 known members of the flavivirus genus include lethal human pathogens such as Yellow Fever, West Nile, and Dengue viruses. There is at present no known chemotherapy for any flavivirus and no effective vaccines for most. A common genomic organization and molecular mechanisms of replication in hosts are shared by flaviviruses with a viral serine protease playing a pivotal role in processing the viral polyprotein into component polypeptides, an obligatory step in viral replication. Using the structure of the dengue serine protease complexed with a protein inhibitor as a template, we have identified five compounds, which inhibit the enzyme. We also describe parallel inhibitory activity of these compounds against the West Nile virus Protease. A few of the compounds appear to provide a template for design of more potent and specific inhibitors of the dengue and West Nile virus proteases. Sequence similarities among flaviviral proteases suggests that such compounds might also possibly inhibit other flaviviral proteases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582469     DOI: 10.1016/j.bmc.2004.09.036

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  25 in total

1.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

2.  Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.

Authors:  Deng-wei Wu; Fei Mao; Yan Ye; Jian Li; Chuan-lian Xu; Xiao-min Luo; Jing Chen; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

3.  Anthracene-based inhibitors of dengue virus NS2B-NS3 protease.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Antiviral Res       Date:  2010-12-23       Impact factor: 5.970

4.  Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Authors:  Lynne Cregar-Hernandez; Guan-Sheng Jiao; Alan T Johnson; Axel T Lehrer; Teri Ann S Wong; Stephen A Margosiak
Journal:  Antivir Chem Chemother       Date:  2011-05-12

5.  Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.

Authors:  Sergey A Shiryaev; Anton V Cheltsov; Katarzyna Gawlik; Boris I Ratnikov; Alex Y Strongin
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

6.  Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors.

Authors:  Szymon Pach; Tim M Sarter; Rafe Yousef; David Schaller; Silke Bergemann; Christoph Arkona; Jörg Rademann; Christoph Nitsche; Gerhard Wolber
Journal:  ACS Med Chem Lett       Date:  2020-03-03       Impact factor: 4.345

7.  Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide.

Authors:  Hussin A Rothan; Zulqarnain Mohamed; Abdulrazzaq M Suhaeb; Noorsaadah Abd Rahman; Rohana Yusof
Journal:  OMICS       Date:  2013-09-17

8.  Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Biochemistry       Date:  2008-10-15       Impact factor: 3.162

9.  NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease.

Authors:  Xun-Cheng Su; Kiyoshi Ozawa; Ruhu Qi; Subhash G Vasudevan; Siew P Lim; Gottfried Otting
Journal:  PLoS Negl Trop Dis       Date:  2009-12-08

10.  Structural optimization and de novo design of dengue virus entry inhibitory peptides.

Authors:  Joshua M Costin; Ekachai Jenwitheesuk; Shee-Mei Lok; Elizabeth Hunsperger; Kelly A Conrads; Krystal A Fontaine; Craig R Rees; Michael G Rossmann; Sharon Isern; Ram Samudrala; Scott F Michael
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.